Abbott Laboratories is set to release its second-quarter earnings on July 17, 2025. Historical data shows a trend of negative one-day returns following earnings reports, with a median negative return of -2.4% and a maximum of -6.5%. Analysts estimate earnings of $1.25 per share on sales of $11.02 billion.

Understanding these historical patterns can influence trading decisions. Traders may choose to position themselves before or after earnings are announced. Abbott Laboratories has a market capitalization of $230 billion and generated $42 billion in revenue over the last twelve months, with $7.1 billion in operating profits and a net income of $14 billion.

Historical data shows that positive one-day post-earnings returns for Abbott Laboratories were observed about 40% of the time over the last five years. The correlation between short-term and medium-term returns post earnings can help traders make informed decisions. Consider the Trefis High Quality portfolio for upside with lower volatility than individual stocks.

Read more at NASDAQ: Should You Buy or Sell Abbott Laboratories Stock Ahead of Its Upcoming Earnings?